tanshinone ii a has been researched along with GRL-0617 in 3 studies
| Studies (tanshinone ii a) | Trials (tanshinone ii a) | Recent Studies (post-2010) (tanshinone ii a) | Studies (GRL-0617) | Trials (GRL-0617) | Recent Studies (post-2010) (GRL-0617) |
|---|---|---|---|---|---|
| 61 | 0 | 41 | 13 | 0 | 12 |
| Protein | Taxonomy | tanshinone ii a (IC50) | GRL-0617 (IC50) |
|---|---|---|---|
| Spike glycoprotein | Betacoronavirus England 1 | 0.6 | |
| Replicase polyprotein 1ab | Betacoronavirus England 1 | 0.6 | |
| Transmembrane protease serine 2 | Homo sapiens (human) | 0.6 | |
| Procathepsin L | Homo sapiens (human) | 0.6 | |
| Replicase polyprotein 1a | Severe acute respiratory syndrome-related coronavirus | 0.6 | |
| Replicase polyprotein 1ab | Human coronavirus 229E | 0.6 | |
| Replicase polyprotein 1ab | Severe acute respiratory syndrome-related coronavirus | 1.1567 | |
| Replicase polyprotein 1ab | Severe acute respiratory syndrome coronavirus 2 | 2.1191 | |
| Spike glycoprotein | Severe acute respiratory syndrome-related coronavirus | 0.6 | |
| Angiotensin-converting enzyme 2 | Homo sapiens (human) | 0.6 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 3 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Easwaran, M; Manickam, M; Pillaiyar, T; Wendt, LL | 1 |
| Hu, Y; Jadhav, P; Tan, B; Tan, H; Wang, J | 1 |
| Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M | 1 |
2 review(s) available for tanshinone ii a and GRL-0617
| Article | Year |
|---|---|
The recent outbreaks of human coronaviruses: A medicinal chemistry perspective.
Topics: Antiviral Agents; Chemistry, Pharmaceutical; COVID-19; Disease Outbreaks; Drug Repositioning; Humans; Virus Internalization | 2021 |
Progress and Challenges in Targeting the SARS-CoV-2 Papain-like Protease.
Topics: Antiviral Agents; Coronavirus Papain-Like Proteases; COVID-19 Drug Treatment; Humans; Pandemics; Protease Inhibitors; SARS-CoV-2 | 2022 |
1 other study(ies) available for tanshinone ii a and GRL-0617
| Article | Year |
|---|---|
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries | 2023 |